$313.13
0.56% today
NYSE, Sep 12, 08:15 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$314.89
+24.10 8.29% 1M
-107.15 25.39% 6M
-54.01 14.64% YTD
-228.50 42.05% 1Y
-178.77 36.21% 3Y
+56.86 22.04% 5Y
+167.80 114.08% 10Y
+239.34 316.80% 20Y
NYSE, Closing price Thu, Sep 11 2025
+8.14 2.65%

Key metrics

Basic
Market capitalization
$70.9b
Enterprise Value
$92.5b
Net debt
$21.6b
Cash
$8.6b
Shares outstanding
224.8m
Valuation (TTM | estimate)
P/E
13.3 | 10.4
P/S
0.4 | 0.4
EV/Sales
0.5 | 0.5
EV/FCF
17.5
P/B
1.6
Dividends
DPS
$6.52
Yield 1Y | 5Y
2.1% | 1.2%
Growth 1Y | 5Y
10.1% | 15.3%
Payout 1Y | 3Y
25.4% | 23.4%
Increased
14 Years
Financials (TTM | estimate)
Revenue
$189.3b | $198.8b
EBITDA
$9.3b | $10.6b
EBIT
$8.7b | $9.7b
Net Income
$5.4b | $6.8b
Free Cash Flow
$5.3b
Growth (TTM | estimate)
Revenue
10.2% | 12.4%
EBITDA
-14.3% | 8.5%
EBIT
-14.3% | 6.1%
Net Income
-19.9% | 13.5%
Free Cash Flow
562.3%
Margin (TTM | estimate)
Gross
-
EBITDA
4.9% | 5.3%
EBIT
4.6%
Net
2.8% | 3.4%
Free Cash Flow
2.8%
Financial Health
Equity Ratio
35.4%
Return on Equity
14.5%
ROCE
7.7%
ROIC
-
Debt/Equity
0.7
More
EPS
$23.7
FCF per Share
$23.5
Short interest
1.4%
Employees
104k
Rev per Employee
$1.7m
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

18x Buy
64%
10x Hold
36%

Analyst Opinions

28 Analysts have issued a Elevance Health forecast:

Buy
64%
Hold
36%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
189,254 189,254
10% 10%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
9,304 9,304
14% 14%
5%
- Depreciation and Amortization 604 604
15% 15%
0%
EBIT (Operating Income) EBIT 8,700 8,700
14% 14%
5%
Net Profit 5,360 5,360
20% 20%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
Business Wire
2 days ago
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned a Long-Term Issue Credit Rating of “bbb+” (Good) to Elevance Health Inc.'s (Elevance Health) (headquartered in Indianapolis, IN) newly issued senior unsecured notes of $750 million, 4.0% senior unsecured notes, due 2028; $750 million, 4.6% senior unsecured notes, due 2032; $1 billion, 5.0% senior unsecured notes, due 2036; and $5...
Neutral
GlobeNewsWire
3 days ago
Bragar Eagel & Squire, P.C. Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Elevance (ELV) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in  Elevance between April 18, 2024, and October 16, 2024 and would like to discuss your legal rights, call Bragar Eagel & Squire partner  Brandon Walker or Marion Passmore directly at (212)...
Positive
Seeking Alpha
4 days ago
ELV stands out as an outperformer due to strong historical performance, capital returns, and a robust balance sheet. Sector tailwinds and AI-driven efficiency gains present attractive long-term opportunities, while ELV trades at a comparatively low valuation. Key risks include unpredictable medical costs that could continue outpacing premium revenue growth, potentially offsetting AI benefits, t...
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,200
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today